ICCM

3.65

6.17% -0.24

Handel nachbörslich: 3.83 0.18 +4.93%

Icecure Medical Ltd (ICCM)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.89

Offen:

$3.81

24-Stunden-Volumen:

124.99K

Relative Volume:

0.04

Marktkapitalisierung:

$12.51M

Einnahmen:

$3.57M

Nettoeinkommen (Verlust:

$-15.74M

KGV:

-0.5253

EPS:

-6.9481

Netto-Cashflow:

$-15.77M

1W Leistung:

-31.90%

1M Leistung:

+43.70%

6M Leistung:

-82.87%

1J Leistung:

-87.95%

1-Tages-Spanne:

$3.55

$3.88

1-Wochen-Bereich:

$3.55

$5.10

52-Wochen-Spanne:

$2.12

$42.00

Icecure Medical Ltd Stock (ICCM) Company Profile

Firmenname

Icecure Medical Ltd

Sektor

Healthcare (1096)

Branche

Medical Devices (140)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-12

Neueste SEC-Einreichungen

ICCM's Discussions on Twitter

Compare ICCM vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ICCM Icecure Medical Ltd	3.65	12.51M	3.57M	-15.74M	-15.77M	-6.9481
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten

08:18 AM

Why Has IceCure Medical's Stock Price Collapsed - Kavout | AI

08:18 AM

Jul 07, 2026

IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer - AOL.com

Jul 07, 2026

Jul 06, 2026

IceCure Medical Ltd. emphasized that following FDA approval for breast cancer treatment, the commercial application of its Prosense™ cryoablation system is continuously expanding in Brazil. - Bitget

Jul 06, 2026

IceCure Medical (ICCM) Expands Presence in Brazil with ProSense System - GuruFocus

Jul 06, 2026

IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer - Barchart.com

Jul 06, 2026

[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan

Jul 06, 2026

Jul 05, 2026

Price to earnings forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView

Jul 05, 2026

Jul 02, 2026

Warrant repricing at IceCure Medical (NASDAQ: ICCM) heads to shareholder vote - Stock Titan

Jul 02, 2026

Jun 30, 2026

IceCure Medical Faces Certified Class Action Over 2021 Private Placement, Plans Court Challenge - The Globe and Mail

Jun 27, 2026

Why Is IceCure (NASDAQ:ICCM) Catching Small-Cap Attention? - Kalkine Media

Jun 27, 2026

IceCure Medical Ltd. Actuals & Estimates (BOATS:ICCM) - TradingView

Jun 27, 2026

Jun 26, 2026

[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC FilingForm 6-K - Stock Titan

Jun 26, 2026

What's Going On With IceCure Medical Stock On Friday? - Benzinga

Jun 26, 2026

IceCure Medical Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail

Jun 26, 2026

Jun 25, 2026

Icecure Medical(ICCM) Stock Options Chain | Quotes & News - Moomoo

Jun 25, 2026

IceCure Medical Files to Register Sale of 5.5 Million Shares by Armistice - marketscreener.com

Jun 25, 2026

ICCM: Selling Stockholders Plan to Offer 5.5 Million Shares - GuruFocus

Jun 25, 2026

IceCure Medical (ICCM) registers 5.5M shares tied to June 2026 warrants - Stock Titan

Jun 25, 2026

ICCM Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026